Search Results - "Sims AC"

Pandemic-driven immune imprinting accelerates evolution of human coronavirus OC43.

Authors: Lu, Shuiping Shen, Qi Wang, Huanru et al.

Source: PLoS Neglected Tropical Diseases. 3/17/2026, Vol. 20 Issue 3, p1-20. 20p.

Attenuated viral strains of priority pathogens for potential use in controlled human infection model studies: A scoping review.

Authors: Hamilton, David Oliver Simpson, Victoria Fox, Tilly et al.

Source: PLoS Neglected Tropical Diseases. 1/2/2026, Vol. 20 Issue 1, p1-18. 18p.

Charting the Impact of Maternal Antibodies and Repeat Exposures on Sapovirus Immunity in Early Childhood From a Nicaraguan Birth Cohort.

Authors: Bucardo F Mallory ML González F et al.

Source: The Journal of infectious diseases [J Infect Dis] 2025 Feb 20; Vol. 231 (2), pp. 480-489.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Predicted antiviral potential of phytochemicals prolific in Cleistanthus bracteosus Jabl. and essential oils of Artemisia scoparia and Thuja orientalis against Nipah virus and Human metapneumovirus: An AI-driven in-silico study.

Authors: Dassanayake, Mackingsley Kushan Khoo, Teng-Jin Chong, Chien Hwa et al.

Source: PLoS ONE. 3/31/2026, Vol. 21 Issue 3, p1-29. 29p.

Proteome-wide characterization of PTMs reveals host cell responses to viral infection and identifies putative antiviral drug targets.

Authors: Li X Kabza A Ives AN et al.

Source: Frontiers in immunology [Front Immunol] 2025 May 30; Vol. 16, pp. 1587106. Date of Electronic Publication: 2025 May 30 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Increased triacylglyceride and ceramide levels are key for MERS-CoV replication.

Authors: Mitchell HD Kyle J Engbrecht K et al.

Source: MSphere [mSphere] 2026 Feb 24; Vol. 11 (2), pp. e0052325. Date of Electronic Publication: 2026 Jan 15.

Publication Type: Journal Article

Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101674533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2379-5042 (Electronic) Linking ISSN: 23795042 NLM ISO Abbreviation: mSphere Subsets: MEDLINE

Bat sarbecovirus WIV1-CoV bears an adaptive mutation that alters spike dynamics and enhances ACE2 binding.

Authors: Tse, Alexandra L. Lasso, Gorka Berrigan, Jacob et al.

Source: PLoS Pathogens. 10/16/2025, Vol. 21 Issue 10, p1-21. 21p.

Heterologous expression of HCoV-HKU1 ORF 7b by mouse hepatitis virus protects against severe disease during murine infection.

Authors: Gunawardene, Chaminda D. Pandey, Isha Chatterjee, Shruti et al.

Source: PLoS Pathogens. 12/5/2025, Vol. 21 Issue 12, p1-22. 22p.

Genome-scale CRISPR screen identifies TMEM198 driving double membrane vesicle formation in swine alphacoronavirus and murine betacoronavirus infected cells.

Authors: Shi, Lei Zhang, Yu Duan, Yueyue et al.

Source: PLoS Pathogens. 5/30/2025, Vol. 21 Issue 5, p1-21. 21p.

Impact of nutrition on long COVID.

Authors: Thangaleela, Subramanian Wang, Chin-Kun

Source: Sports Medicine & Health Science (SMHS). Mar2026, Vol. 8 Issue 2, p128-144.

Efficacy and safety of remdesivir for patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review of randomized controlled trials.

Authors: Meena, Jitendra Agarwal, Amit Sandhu, Amit et al.

Source: Indian Journal of Pharmacology. Mar/Apr2026, Vol. 58 Issue 2, p137-141. 5p.

Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study.

Authors: Bagheri, Yasin Malekinejad, Zahra Hejazian, Seyyedeh Mina et al.

Source: PLoS ONE. 2/12/2026, Vol. 21 Issue 2, p1-13. 13p.

Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses.

Authors: Tse, Alexandra L. Acreman, Cory M. Ricardo-Lax, Inna et al.

Source: PLoS Pathogens. 11/15/2024, Vol. 20 Issue 11, p1-33. 33p.

Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective DOI-RECOVER study.

Authors: Pieralli, Filippo Pomero, Fulvio Dentali, Francesco et al.

Source: BMC Infectious Diseases. 7/8/2023, Vol. 23 Issue 1, p1-8. 8p.

Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.

Authors: Veronese, Nicola Di Gennaro, Francesco Frallonardo, Luisa et al.

Source: Scientific Reports. 4/23/2024, Vol. 14 Issue 1, p1-7. 7p.

Unraveling the metabolic potential and roles of reductases in the omicsynin biosynthetic gene cluster.

Authors: Li, Yihong Fu, Jie Sun, Hongmin et al.

Source: Natural Products & Bioprospecting. 1/9/2026, Vol. 16 Issue 1, p1-12. 12p.

Discovery of benzyl carbamate inhibitors of coronavirus M^pro enzymes from a legacy collection of cysteine protease inhibitors.

Authors: Sá Magalhães Serafim, Mateus Kronenberger, Thales Francisco, Karol R. et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2025, Vol. 40 Issue 1, p1-24. 24p.

Remdesivir-Induced Hepatotoxicity: A Systematic Review of Clinical Evidence, Pharmacokinetics, and Safety Concerns.

Authors: Hamdan, Angkasa Ramatuan Bestari, Muhamad Begawan Girawan, Dolvy et al.

Source: Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy. Dec2025, Vol. 26 Issue 3, p228-236. 9p.

Nipah virus: pathogenesis, genome, diagnosis, and treatment.

Authors: Madhukalya, Rishav Yadav, Urvashi Parray, Hilal Ahmad et al.

Source: Applied Microbiology & Biotechnology; 7/1/2025, Vol. 109 Issue 1, p1-27, 27p

In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19.

Authors: Aqeel, Imra Majid, Abdul Alahmadi, Tahani Jaser et al.

Source: PLoS ONE. 6/25/2025, Vol. 20 Issue 6, p1-21. 21p.